Denis Claude Roy

Director of the Cellular Therapy Laboratory; Scientific Director of the Centre de recherche Hôpital Maisonneuve-Rosemont
Full Professor, Université de Montréal
Adjunct professor, McGill University

Full Biography

Cancers of Interest

Blood cancers: leukemia, lymphoma, myeloma, etc.

Research Interests and Clinical Approach

Immunotherapy
Immunotolerance

Projects at BioCanRx

An Interventional, Open-label, Non-randomized Dose-escalation Phase I Multicenter Clinical Trial of Multi-peptide Anti-minor Histocompatibility Antigen Immunotherapy for the Prevention of Relapse in Patients with High-risk Malignancy Eligible for Matched Related ASCT

Phase I clinical trial of Anti-Minor Histocompatibility Antigen Immunotherapy Broadening the Scope of Application for Precision Therapeutics

DEVELOPING T CELLS THAT TARGET ANTIGENS SPECIFIC TO LYMPHOID CANCERS

Recent Articles

2017 Summit for Cancer Immunotherapy

BioCanRx Summer Students Tell All

Introducing the winners of BioCanRx’s 2018 Summer Studentships

BioCanRx and Partners Announce Funding for a New Clinical Trial to Treat Hematologic Cancers